A soluble form of LMIR5/CD300b amplifies lipopolysaccharide-induced lethal inflammation in sepsis

Journal of Immunology

Volumn 189, Issue 4, 2012, Pages 1773-1779

  Yamanishi, Yoshinori ^a,b   Takahashi, Mariko ^a   Izawa, Kumi ^a   Isobe, Masamichi ^a   Ito, Shinichi ^a   Tsuchiya, Akiho ^a   Maehara, Akie ^a   Kaitani, Ayako ^a   Uchida, Tomoyuki ^a   Togami, Katsuhiro ^a   Enomoto, Yutaka ^a   Nakahara, Fumio ^a   Oki, Toshihiko ^a   Kajikawa, Masunori ^c   Kurihara, Hiroki ^b   Kitamura, Toshio ^a   Kitaura, Jiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c ACTGen Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 5; LIPOPOLYSACCHARIDE; MEMBRANE RECEPTOR; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEFICIENCY; PROTEIN SECRETION; SEPSIS;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NEUTROPHILS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC; SEPSIS; SOLUBILITY; TRANSFECTION;

EID: 84864810588     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201139     Document Type: Article

References (37)

1. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891. (Pubitemid 36019643)
2. Riedemann, N. C., R. F. Guo, and P. A. Ward. 2003. Novel strategies for the treatment of sepsis. Nat. Med. 9: 517-524. (Pubitemid 36597096)
3. Buras, J. A., B. Holzmann, and M. Sitkovsky. 2005. Animal models of sepsis: setting the stage. Nat. Rev. Drug Discov. 4: 854-865. (Pubitemid 41553966)
4. Hotchkiss, R. S., and D. W. Nicholson. 2006. Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6: 813-822. (Pubitemid 44631650)
5. Rittirsch, D., M. A. Flierl, and P. A.Ward. 2008. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8: 776-787.
6. Palm, N. W., and R. Medzhitov. 2009. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 227: 221-233.
7. Aderem, A., and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
8. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263. (Pubitemid 38902439)
9. Ivashkiv, L. B. 2009. Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 10: 340-347.
10. Blank, U., P. Launay, M. Benhamou, and R. C. Monteiro. 2009. Inhibitory ITAMs as novel regulators of immunity. Immunol. Rev. 232: 59-71.
11. Kumagai, H., T. Oki, K. Tamitsu, S. Z. Feng, M. Ono, H. Nakajima, Y. C. Bao, Y. Kawakami, K. Nagayoshi, N. G. Copeland, et al. 2003. Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem. Biophys. Res. Commun. 307: 719-729. (Pubitemid 36944992)
12. Izawa, K., J. Kitaura, Y. Yamanishi, T. Matsuoka, T. Oki, F. Shibata, H. Kumagai, H. Nakajima, M. Maeda-Yamamoto, J. P. Hauchins, et al. 2007. Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. J. Biol. Chem. 282: 17997-18008. (Pubitemid 47100247)
13. Yamanishi, Y., J. Kitaura, K. Izawa, T. Matsuoka, T. Oki, Y. Lu, F. Shibata, S. Yamazaki, H. Kumagai, H. Nakajima, et al. 2008. Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. Blood 111: 688-698.
14. Izawa, K., J. Kitaura, Y. Yamanishi, T. Matsuoka, A. Kaitani, M. Sugiuchi, M. Takahashi, A. Maehara, Y. Enomoto, T. Oki, et al. 2009. An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells. J. Immunol. 183: 925-936.
15. Yamanishi, Y., J. Kitaura, K. Izawa, A. Kaitani, Y. Komeno, M. Nakamura, S. Yamazaki, Y. Enomoto, T. Oki, H. Akiba, et al. 2010. TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J. Exp. Med. 207: 1501-1511.
16. Ravetch, J. V., and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290: 84-89.
17. Lanier, L. L. 2009. DAP10- and DAP12-associated receptors in innate immunity. Immunol. Rev. 227: 150-160.
18. Chung, D. H., M. B. Humphrey, M. C. Nakamura, D. G. Ginzinger, W. E. Seaman, and M. R. Daws. 2003. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J. Immunol. 171: 6541-6548.
19. Yotsumoto, K., Y. Okoshi, K. Shibuya, S. Yamazaki, S. Tahara-Hanaoka, S. Honda, M. Osawa, A. Kuroiwa, Y. Matsuda, D. G. Tenen, et al. 2003. Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation. J. Exp. Med. 198: 223-233. (Pubitemid 36987850)
20. Kuchroo, V. K., D. T. Umetsu, R. H. DeKruyff, and G. J. Freeman. 2003. The TIM gene family: emerging roles in immunity and disease. Nat. Rev. Immunol. 3: 454-462. (Pubitemid 37339185)
21. Ichimura, T., J. V. Bonventre, V. Bailly, H. Wei, C. A. Hession, R. L. Cate, and M. Sanicola. 1998. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273: 4135-4142. (Pubitemid 28103282)
22. Bouchon, A., F. Facchetti, M. A. Weigand, and M. Colonna. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410: 1103-1107. (Pubitemid 32391042)
23. Klesney-Tait, J., I. R. Turnbull, and M. Colonna. 2006. The TREM receptor family and signal integration. Nat. Immunol. 7: 1266-1273. (Pubitemid 46111244)
24. Ford, J. W., and D. W. McVicar. 2009. TREM and TREM-like receptors in inflammation and disease. Curr. Opin. Immunol. 21: 38-46.
25. Gibot, S., M. N. Kolopp-Sarda, M. C. Béné, P. E. Bollaert, A. Lozniewski, F. Mory, B. Levy, and G. C. Faure. 2004. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J. Exp. Med. 200: 1419-1426. (Pubitemid 39657289)
26. Knapp, S., S. Gibot, A. de Vos, H. H. Versteeg, M. Colonna, and T. van der Poll. 2004. Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J. Immunol. 173: 7131-7134. (Pubitemid 39628147)
27. Kitaura, J., J. Song, M. Tsai, K. Asai, M. Maeda-Yamamoto, A. Mocsai, Y. Kawakami, F. T. Liu, C. A. Lowell, B. G. Barisas, et al. 2003. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc. Natl. Acad. Sci. USA 100: 12911-12916. (Pubitemid 37339999)
28. Mócsai, A., E. Ligeti, C. A. Lowell, and G. Berton. 1999. Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck. J. Immunol. 162: 1120-1126. (Pubitemid 29035443)
29. Shiratori, I., K. Ogasawara, T. Saito, L. L. Lanier, and H. Arase. 2004. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J. Exp. Med. 199: 525-533. (Pubitemid 38233836)
30. Kitamura, T., Y. Koshino, F. Shibata, T. Oki, H. Nakajima, T. Nosaka, and H. Kumagai. 2003. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31: 1007-1014. (Pubitemid 37329742)
31. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066. (Pubitemid 30398356)
32. Traeger, T., W. Kessler, V. Assfalg, K. Cziupka, P. Koerner, C. Dassow, K. Breitbach, M. Mikulcak, I. Steinmetz, K. Pfeffer, et al. 2008. Detrimental role of CC chemokine receptor 4 in murine polymicrobial sepsis. Infect. Immun. 76: 5285-5293.
33. Renckens, R., J. J. Roelofs, S. Florquin, A. F. de Vos, H. R. Lijnen, C. van't Veer, and T. van der Poll. 2006. Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J. Immunol. 176: 3735-3741. (Pubitemid 43364020)
34. Tester, A. M., J. H. Cox, A. R. Connor, A. E. Starr, R. A. Dean, X. S. Puente, C. López-Otín, and C. M. Overall. 2007. LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS ONE 2: e312.
35. Rodriguez-Manzanet, R., R. DeKruyff, V. K. Kuchroo, and D. T. Umetsu. 2009. The costimulatory role of TIM molecules. Immunol. Rev. 229: 259-270.
36. Gómez-Piña, V., A. Soares-Schanoski, A. Rodríguez- Rojas, C. Del Fresno, F. García, M. T. Vallejo-Cremades, I. Fernández-Ruiz, F. Arnalich, P. Fuentes-Prior, and E. López-Collazo. 2007. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J. Immunol. 179: 4065-4073.
37. Turnbull, I. R., J. E. McDunn, T. Takai, R. R. Townsend, J. P. Cobb, and M. Colonna. 2005. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J. Exp. Med. 202: 363-369. (Pubitemid 41126953)